These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21437708)

  • 1. A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis.
    Chatterjee S; Biondi I; Dyson PJ; Bhattacharyya A
    J Biol Inorg Chem; 2011 Jun; 16(5):715-24. PubMed ID: 21437708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs.
    Ang WH; De Luca A; Chapuis-Bernasconi C; Juillerat-Jeanneret L; Lo Bello M; Dyson PJ
    ChemMedChem; 2007 Dec; 2(12):1799-806. PubMed ID: 17918761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
    Aird RE; Cummings J; Ritchie AA; Muir M; Morris RE; Chen H; Sadler PJ; Jodrell DI
    Br J Cancer; 2002 May; 86(10):1652-7. PubMed ID: 12085218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1.
    Ratanaphan A; Nhukeaw T; Hongthong K; Dyson PJ
    Anticancer Agents Med Chem; 2017; 17(2):212-220. PubMed ID: 27039925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic organometallic anticancer complexes.
    Dougan SJ; Habtemariam A; McHale SE; Parsons S; Sadler PJ
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11628-33. PubMed ID: 18687892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organometallic ruthenium anticancer complexes inhibit human glutathione-S-transferase π.
    Lin Y; Huang Y; Zheng W; Wang F; Habtemariam A; Luo Q; Li X; Wu K; Sadler PJ; Xiong S
    J Inorg Biochem; 2013 Nov; 128():77-84. PubMed ID: 23942162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of anticancer role of a novel ruthenium(II)-based compound compared with NAMI-A and cisplatin in impairing mitochondrial functionality and promoting oxidative stress in triple negative breast cancer models.
    Silvestri S; Cirilli I; Marcheggiani F; Dludla P; Lupidi G; Pettinari R; Marchetti F; Di Nicola C; Falcioni G; Marchini C; Orlando P; Tiano L; Amici A
    Mitochondrion; 2021 Jan; 56():25-34. PubMed ID: 33220497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying the metal to ethacrynic acid ratio in ruthenium(ii)/osmium(ii)-p-cymene conjugates.
    Păunescu E; Soudani M; Clavel CM; Dyson PJ
    J Inorg Biochem; 2017 Oct; 175():198-207. PubMed ID: 28779652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer.
    Ruiz MC; Kljun J; Turel I; Di Virgilio AL; León IE
    Metallomics; 2019 Mar; 11(3):666-675. PubMed ID: 30839008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T.
    Nhukeaw T; Hongthong K; Dyson PJ; Ratanaphan A
    Apoptosis; 2019 Aug; 24(7-8):612-622. PubMed ID: 31016421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity.
    Fabijańska M; Kasprzak MM; Ochocki J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells.
    Guo W; Zheng W; Luo Q; Li X; Zhao Y; Xiong S; Wang F
    Inorg Chem; 2013 May; 52(9):5328-38. PubMed ID: 23586415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways.
    Chatterjee S; Kundu S; Bhattacharyya A; Hartinger CG; Dyson PJ
    J Biol Inorg Chem; 2008 Sep; 13(7):1149-55. PubMed ID: 18597125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.
    Chen L; Li G; Peng F; Jie X; Dongye G; Cai K; Feng R; Li B; Zeng Q; Lun K; Chen J; Xu B
    Oncotarget; 2016 Dec; 7(49):80716-80734. PubMed ID: 27811372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells.
    Silva VR; Corrêa RS; Santos LS; Soares MBP; Batista AA; Bezerra DP
    Sci Rep; 2018 Jan; 8(1):288. PubMed ID: 29321581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of an organometallic ruthenium complex as a potential myorelaxant drug.
    Trobec T; Žužek MC; Sepčić K; Kladnik J; Kljun J; Turel I; Benoit E; Frangež R
    Biomed Pharmacother; 2020 Jul; 127():110161. PubMed ID: 32380389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered DNA binding and amplification of human breast cancer suppressor gene BRCA1 induced by a novel antitumor compound, [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)].
    Chakree K; Ovatlarnporn C; Dyson PJ; Ratanaphan A
    Int J Mol Sci; 2012 Oct; 13(10):13183-202. PubMed ID: 23202946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity.
    Liu S; Liang A; Wu K; Zeng W; Luo Q; Wang F
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549).
    Vilanova-Costa CA; Porto HK; Pereira Fde C; de Lima AP; Dos Santos WB; Silveira-Lacerda Ede P
    Biometals; 2014 Jun; 27(3):459-69. PubMed ID: 24781824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
    Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
    BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.